Clinical Trial Update: A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating desvenlafaxine sustained-release (DVS SR) for fibromyalgia in adult female outpatients; the trial was terminated and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Desvenlafaxine Sustained-Release (DVS-SR) (desvenlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Fibromyalgia | Phase 2 | Status: TERMINATED | Results posted: 2010-02-23